121.00
-1.40 (-1.14%)
| Penutupan Terdahulu | 122.40 |
| Buka | 128.00 |
| Jumlah Dagangan | 359,925 |
| Purata Dagangan (3B) | 846,879 |
| Modal Pasaran | 292,437,696 |
| Harga / Pendapatan (P/E TTM) | 9.31 |
| Harga / Jualan (P/S) | 65.25 |
| Harga / Buku (P/B) | 1.07 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Aug 2025 |
| Margin Keuntungan | 1,108.33% |
| Margin Operasi (TTM) | -1,530.20% |
| EPS Cair (TTM) | 0.160 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 2,422.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 40.59% |
| Nisbah Semasa (MRQ) | 9.33 |
| Aliran Tunai Operasi (OCF TTM) | -134.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -69.31 M |
| Pulangan Atas Aset (ROA TTM) | -13.10% |
| Pulangan Atas Ekuiti (ROE TTM) | 6.41% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (GB) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | PURETECH HEALTH PLC ORD 1P | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.25 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| PURETECH HEALTH PLC ORD 1P | 292 M | - | 9.31 | 1.07 |
| RELIEF THERAPEUTICS HOLDING SA | 2 B | - | - | 1.08 |
| IDORSIA LTD IDORSIA N ORD SHS | 1 B | - | - | - |
| OXFORD NANOPORE TECHNOLOGIES PL | 1 B | - | - | 2.30 |
| IOVANCE BIOTHERAPEUTICS INC IOV | 304 M | - | - | - |
| FARON PHARMACEUTICALS OY ORD NP | 231 M | - | - | 165.73 |
|
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 14.67% |
| % Dimiliki oleh Institusi | 66.90% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |